... >
organooxygen compound >
ester >
carboxylic ester >
lactone >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
... >
organooxygen compound >
carbonyl compound >
carboxylic ester >
lactone >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
organooxygen compound >
ester >
lactone >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
... >
organooxygen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
amide >
primary amide >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
اصطلاح مرجح
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
اینچی
-
InChI=1S/C35H53N5O7/c1-21(2)19-27-33(44)39(8)30(23(5)6)34(45)38(7)29(22(3)4)32(43)37-25(20-24-13-10-9-11-14-24)31(42)36-17-16-28(41)40-18-12-15-26(40)35(46)47-27/h9-11,13-14,21-23,25-27,29-30H,12,15-20H2,1-8H3,(H,36,42)(H,37,43)
اینچیکی
-
RPJBXUNEXVNBIF-UHFFFAOYSA-N
اسمایلٓ
-
O1C(=O)C2N(CCC2)C(=O)CCNC(=O)C(NC(=O)C(N(C(=O)C(N(C(=O)C1CC(C)C)C)C(C)C)C)C(C)C)CC3=CC=CC=C3
مترادف دقیق
-
7-benzyl-11,14-dimethyl-16-(2-methylpropyl)-10,13-di(propan-2-yl)-17-oxa-1,5,8,11,14-pentazabicyclo[17.3.0]docosane-2,6,9,12,15,18-hexone
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:183894